NZ328639A - Phenyl-substituted alkenylcarboxylic acid guanidines; preparation and medicaments - Google Patents

Phenyl-substituted alkenylcarboxylic acid guanidines; preparation and medicaments

Info

Publication number
NZ328639A
NZ328639A NZ328639A NZ32863997A NZ328639A NZ 328639 A NZ328639 A NZ 328639A NZ 328639 A NZ328639 A NZ 328639A NZ 32863997 A NZ32863997 A NZ 32863997A NZ 328639 A NZ328639 A NZ 328639A
Authority
NZ
New Zealand
Prior art keywords
medicaments
phenyl
preparation
alkenylcarboxylic acid
substituted alkenylcarboxylic
Prior art date
Application number
NZ328639A
Other languages
English (en)
Inventor
Jan-Robert Schwark
Joachim Brendel
Heinz-Werner Kleemann
Hans Jochen Lang
Andreas Weichert
Hans-Willi Jansen
Wolfgang Scholz
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NZ328639A publication Critical patent/NZ328639A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NZ328639A 1996-08-22 1997-08-20 Phenyl-substituted alkenylcarboxylic acid guanidines; preparation and medicaments NZ328639A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19633966A DE19633966A1 (de) 1996-08-22 1996-08-22 Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
NZ328639A true NZ328639A (en) 1999-01-28

Family

ID=7803413

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ328639A NZ328639A (en) 1996-08-22 1997-08-20 Phenyl-substituted alkenylcarboxylic acid guanidines; preparation and medicaments

Country Status (29)

Country Link
US (1) US6005010A (cg-RX-API-DMAC7.html)
EP (1) EP0825178B1 (cg-RX-API-DMAC7.html)
JP (1) JP4081159B2 (cg-RX-API-DMAC7.html)
KR (1) KR19980018898A (cg-RX-API-DMAC7.html)
CN (1) CN1065861C (cg-RX-API-DMAC7.html)
AR (1) AR008305A1 (cg-RX-API-DMAC7.html)
AT (1) ATE202338T1 (cg-RX-API-DMAC7.html)
AU (1) AU713664B2 (cg-RX-API-DMAC7.html)
BR (1) BR9704483A (cg-RX-API-DMAC7.html)
CA (1) CA2213714C (cg-RX-API-DMAC7.html)
CZ (1) CZ265997A3 (cg-RX-API-DMAC7.html)
DE (2) DE19633966A1 (cg-RX-API-DMAC7.html)
DK (1) DK0825178T3 (cg-RX-API-DMAC7.html)
ES (1) ES2158413T3 (cg-RX-API-DMAC7.html)
GR (1) GR3036123T3 (cg-RX-API-DMAC7.html)
HR (1) HRP970450B1 (cg-RX-API-DMAC7.html)
HU (1) HUP9701416A3 (cg-RX-API-DMAC7.html)
ID (1) ID18066A (cg-RX-API-DMAC7.html)
IL (1) IL121590A (cg-RX-API-DMAC7.html)
MX (1) MX9706380A (cg-RX-API-DMAC7.html)
NO (1) NO309468B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ328639A (cg-RX-API-DMAC7.html)
PL (1) PL321748A1 (cg-RX-API-DMAC7.html)
PT (1) PT825178E (cg-RX-API-DMAC7.html)
RU (1) RU2193026C2 (cg-RX-API-DMAC7.html)
SI (1) SI0825178T1 (cg-RX-API-DMAC7.html)
SK (1) SK282632B6 (cg-RX-API-DMAC7.html)
TR (1) TR199700827A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA977494B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19633966A1 (de) * 1996-08-22 1998-02-26 Hoechst Ag Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19849722A1 (de) * 1998-10-28 2000-05-04 Aventis Pharma Gmbh Substituierte Phenyl-alkenoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU4707900A (en) * 1999-05-07 2000-11-21 Trustees Of The University Of Pennsylvania, The Methods for controlling intraocular pressure
DE19960204A1 (de) * 1999-12-14 2001-06-28 Aventis Pharma Gmbh Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10015248A1 (de) * 2000-03-28 2001-10-04 Merck Patent Gmbh Bisamidino-Verbindungen als NHE-3 Inhibitoren
DE10046993A1 (de) * 2000-09-22 2002-04-11 Aventis Pharma Gmbh Substituierte Zimtsäureguanidide, Verfahren zur ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltendes Medikament
DE10063294A1 (de) 2000-12-19 2002-07-04 Aventis Pharma Gmbh Substituierte Heterocyclo-Norbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10161767A1 (de) * 2001-12-15 2003-06-26 Merck Patent Gmbh 2-Guanidino-4-heterocyclyl-chinazoline
US20030187045A1 (en) * 2001-12-21 2003-10-02 Uwe Heinelt Substituted imidazolidines, process for their preparation, and their use as a medicament or diagnostic
DE10163239A1 (de) * 2001-12-21 2003-07-10 Aventis Pharma Gmbh Substituierte Imidazolidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie enthaltendes Medikament
US7049333B2 (en) 2002-06-04 2006-05-23 Sanofi-Aventis Deutschland Gmbh Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
US20050054705A1 (en) * 2003-02-04 2005-03-10 Aventis Pharma Deutschland Gmbh N-substituted (benzoimidazol-2-yl) phenylamines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
DE10304374A1 (de) * 2003-02-04 2004-08-05 Aventis Pharma Deutschland Gmbh Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE10341240A1 (de) 2003-09-08 2005-04-07 Aventis Pharma Deutschland Gmbh Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE102005001411A1 (de) 2005-01-12 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
DE602008002440D1 (de) 2007-06-28 2010-10-14 Sanofi Aventis Us Llc Verfahren zur herstellung von n-(2-chlor-4-methyl-3-thienyl)-1h-benzimidazol- 2-amin hydrochlorid und zwischenprodukte dafür
WO2009054545A1 (ja) * 2007-10-26 2009-04-30 Jsr Corporation 液晶配向剤、液晶配向膜の形成方法及び液晶表示素子
RU2522586C2 (ru) 2008-09-02 2014-07-20 Санофи-Авентис Замещенные аминоинданы и их аналоги, и их применение в фармацевтике
JP5502106B2 (ja) 2008-12-31 2014-05-28 アーデリクス，インコーポレーテッド 体液貯留または塩分過負荷と関連する障害および消化管障害の治療におけるｎｈｅ媒介性アンチポートを阻害するための組成物および方法
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US20120088737A2 (en) * 2009-10-02 2012-04-12 Ajinomoto Co., Inc Novel acyl guanidine derivatives
WO2014029983A1 (en) 2012-08-21 2014-02-27 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US10376481B2 (en) 2012-08-21 2019-08-13 Ardelyx, Inc. Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
PT2983667T (pt) 2013-04-12 2019-07-11 Ardelyx Inc Compostos e métodos de ligação ao nhe3 para inibir o transporte de fosfato
US11147884B2 (en) 2017-01-09 2021-10-19 Ardelyx, Inc. Inhibitors of NHE-mediated antiport
JP7292207B2 (ja) 2017-01-09 2023-06-16 アルデリックス， インコーポレイテッド 消化管障害を処置するために有用な化合物
KR20200074085A (ko) 2017-08-04 2020-06-24 알데릭스, 인코포레이티드 고칼륨혈증 치료를 위한 글리시레틴산 유도체
SG11202108541RA (en) 2019-02-07 2021-09-29 Ardelyx Inc Glycyrrhetinic acid derivatives for use in treating hyperkalemia
EP3972599B1 (en) 2019-05-21 2025-10-22 Ardelyx, Inc. Combination for lowering serum phosphate in a patient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19633966A1 (de) * 1996-08-22 1998-02-26 Hoechst Ag Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
HRP970450A2 (en) 1998-08-31
CN1174833A (zh) 1998-03-04
ZA977494B (en) 1998-02-23
NO973850D0 (no) 1997-08-21
PT825178E (pt) 2001-10-30
HUP9701416A2 (hu) 1998-03-30
HU9701416D0 (en) 1997-10-28
AU713664B2 (en) 1999-12-09
NO973850L (no) 1998-02-23
NO309468B1 (no) 2001-02-05
JPH10109970A (ja) 1998-04-28
HUP9701416A3 (en) 1998-07-28
DE59703851D1 (de) 2001-07-26
EP0825178A1 (de) 1998-02-25
CA2213714C (en) 2007-08-14
IL121590A0 (en) 1998-02-08
US6005010A (en) 1999-12-21
DK0825178T3 (da) 2001-09-03
JP4081159B2 (ja) 2008-04-23
KR19980018898A (ko) 1998-06-05
SK113897A3 (en) 1998-03-04
MX9706380A (es) 1998-02-28
PL321748A1 (en) 1998-03-02
CN1065861C (zh) 2001-05-16
ID18066A (id) 1998-02-26
ES2158413T3 (es) 2001-09-01
AU3519297A (en) 1998-02-26
RU2193026C2 (ru) 2002-11-20
EP0825178B1 (de) 2001-06-20
TR199700827A2 (xx) 1998-03-21
CA2213714A1 (en) 1998-02-22
GR3036123T3 (en) 2001-09-28
CZ265997A3 (cs) 1998-03-18
SK282632B6 (sk) 2002-10-08
ATE202338T1 (de) 2001-07-15
DE19633966A1 (de) 1998-02-26
AR008305A1 (es) 1999-12-29
HRP970450B1 (en) 2003-02-28
SI0825178T1 (en) 2001-10-31
BR9704483A (pt) 1998-12-29
IL121590A (en) 2002-05-23

Similar Documents

Publication Publication Date Title
NZ328639A (en) Phenyl-substituted alkenylcarboxylic acid guanidines; preparation and medicaments
EP0950665A4 (en) PHYSIOLOGICALLY ACTIVE MODIFIED PROTEINS AND DRUG COMPOSITIONS CONTAINING THEM
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
AU1732395A (en) Certain cerulenin-geranyl and dodecanoic acid derivatives
ZA979175B (en) Novel piperidineketocarboxylic acid derivatives their preparation and use
PL332547A1 (en) Skin care compositions containing an acid and retinoide
HUP0100900A3 (en) Pharmaceutically active morpholinol and medicaments containing them
AU2330892A (en) Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions
AU7319994A (en) Nucleotide preparation and uses thereof in wound healing
ZA973097B (en) Novel aspire-hydroxy acid derivatives their preparation and use
IL115899A0 (en) 2-[(2-alkoxy-6-trifluoromethylpyrimidin-4-yl) oxymethylene]-phenylacetic acid derivatives their preparation and use thereof
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
HUP0100102A3 (en) Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
IL116480A0 (en) Acetic acid deriratives their preparation and pharmaceutical compositions containing them
AU2689995A (en) Use of dipyridamole and analogs thereof in preventing adhesion formation
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
AU3695297A (en) Alfa-amino acid amides, preparation thereof and the therapeutical use thereof
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU7001796A (en) Benzoic acid compounds and medicinal use thereof
AU691677B2 (en) Tetrahydroisoquinoline derivative and medicinal preparation containing the same
AU1637195A (en) Preparation of 3-mercaptopropionitrile and 3-mercaptopropionic acid
AU5647096A (en) Combined preparations with vascular effect containing dihydr opyridines, acetylsalicylic acid nitroesters and vitamins
ZA986047B (en) 6-pyrrolidin-2-ylpyrindines their preparation and their therapeutic application
AU3439393A (en) Medical grade adhesives and their preparation
HUP0004661A3 (en) Polyhydroxybutylpyrazines, their preparation and medicines containing them

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)